| Texto completo | |
| Autor(es): |
Magalhaes, Taciani de Almeida
[1]
;
Borges, Kleiton Silva
[2]
;
de Sousa, Graziella Ribeiro
[1]
;
Brandalise, Silvia Regina
[3, 4]
;
Seidinger, Ana Luiza
[3, 4]
;
Scrideli, Carlos Alberto
[2]
;
Oba-Shinjo, Sueli Mieko
[5]
;
Yunes, Jose Andres
[3, 4]
;
Tone, Luiz Gonzaga
[1, 2]
Número total de Autores: 9
|
| Afiliação do(s) autor(es): | [1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP - Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP - Brazil
[3] Univ Estadual Campinas, Fac Med Sci, Med Genet Dept, Campinas, SP - Brazil
[4] Boldrini Childrens Ctr, Mol Biol Lab, Campinas, SP - Brazil
[5] Univ Sao Paulo, Fac Med, Dept Neurol, Lab Cellular & Mol Biol, Sao Paulo, SP - Brazil
Número total de Afiliações: 5
|
| Tipo de documento: | Artigo Científico |
| Fonte: | NEUROLOGICAL SCIENCES; v. 41, n. 3, p. 691-694, MAR 2020. |
| Citações Web of Science: | 0 |
| Resumo | |
Background Ependymoma (EPN) is the third most common childhood cancer of the central nervous system. RELA fusion-positive EPN accounts for approximately 70% of all childhood supratentorial tumors and shows the worst prognosis among the supratentorial EPNs. TP53 mutation is infrequent in RELA fusions EPNs. In the population from the Southern region of Brazil, there is a high incidence of the germline TP53 p.R337H mutation that predisposes carriers to develop early-onset tumors. However, despite this high incidence, the frequency of this mutation among EPN patients remains to be determined. Here, we investigated the presence of the TP53 p.R337H mutation in a larger cohort of pediatric EPNs of three institutions located in the state of Sao Paulo, Brazil. Methods The TP53 p.R337H mutation was screened by conventional RT-PCR and Sanger sequencing in 49 pediatric EPNs diagnosed during the period from 1995 to 2016. Results We described for the first time a case of a 5-year-old girl with RELA fusion EPN with a heterozygous TP53 p.R337H mutation. Conclusions The present finding indicates that the TP53 p.R337H germline mutation is uncommon in patients with EPN in Brazil and screening of pediatric patients RELA fusion EPN may be informative to better understand the role of TP53 germline mutations in the development and prognosis of these tumors. (AU) | |
| Processo FAPESP: | 16/19820-6 - Investigação de novos alvos terapêuticos a partir de redes transcricionais de genes do fuso mitótico associadas com vias de desenvolvimento embrionário no ependimoma: enfoque nos subgrupos moleculares de pior prognóstico |
| Beneficiário: | Taciani de Almeida Magalhães |
| Modalidade de apoio: | Bolsas no Brasil - Doutorado |
| Processo FAPESP: | 14/20341-0 - Interação entre alvos terapêuticos emergentes e vias de desenvolvimento associadas à tumorigênese: ênfase em neoplasias da criança e do adolescente |
| Beneficiário: | Luiz Gonzaga Tone |
| Modalidade de apoio: | Auxílio à Pesquisa - Temático |
| Processo FAPESP: | 15/03614-5 - Detalhamento funcional do papel de CD99 em astrocitomas |
| Beneficiário: | Sueli Mieko Oba Shinjo |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |